These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29237998)

  • 1. Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan.
    Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Matsumura T; Kokado H; Gildea S; Cullinane A
    J Vet Med Sci; 2018 Mar; 80(2):382-386. PubMed ID: 29237998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update of inactivated equine influenza vaccine strain in Japan.
    Gamoh K; Nakamura S
    J Vet Med Sci; 2017 Mar; 79(3):649-653. PubMed ID: 28163276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of antigenic difference of equine influenza virus strains by challenge study in horses.
    Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Kondo T; Matsumura T; Gildea S; Cullinane A
    Influenza Other Respir Viruses; 2016 Nov; 10(6):536-539. PubMed ID: 27465864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 May; 29(22):3917-22. PubMed ID: 21419776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
    Paillot R; Prowse L; Montesso F; Huang CM; Barnes H; Escala J
    Vet Microbiol; 2013 Mar; 162(2-4):396-407. PubMed ID: 23146168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impact of a single amino-acid substitution on the efficacy of equine influenza vaccines.
    Yamanaka T; Cullinane A; Gildea S; Bannai H; Nemoto M; Tsujimura K; Kondo T; Matsumura T
    Equine Vet J; 2015 Jul; 47(4):456-62. PubMed ID: 24773030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic differences between equine influenza virus vaccine strains and Florida sublineage clade 1 strains isolated in Europe in 2019.
    Nemoto M; Ohta M; Yamanaka T; Kambayashi Y; Bannai H; Tsujimura K; Yamayoshi S; Kawaoka Y; Cullinane A
    Vet J; 2021 Jun; 272():105674. PubMed ID: 33941332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study.
    Daly JM; Sindle T; Tearle J; Barquero N; Newton JR; Corning S
    Equine Vet J; 2007 Sep; 39(5):446-50. PubMed ID: 17910270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refinement of the equine influenza model in the natural host: A meta-analysis to determine the benefits of individual nebulisation for experimental infection and vaccine evaluation in the face of decreased strain pathogenicity.
    Garrett D; Montesso F; Fougerolle S; Lopez-Alvarez MR; Birand I; De Bock M; Huang CM; Legrand L; Pronost S; Paillot R
    Vet Microbiol; 2017 Nov; 211():150-159. PubMed ID: 29102112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model.
    Pavulraj S; Virmani N; Bera BC; Joshi A; Anand T; Virmani M; Singh R; Singh RK; Tripathi BN
    Vet Microbiol; 2017 Oct; 210():188-196. PubMed ID: 29103691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of the epidemic strain of H3N8 equine influenza virus responsible for outbreaks in South America in 2012.
    Alves Beuttemmüller E; Woodward A; Rash A; Dos Santos Ferraz LE; Fernandes Alfieri A; Alfieri AA; Elton D
    Virol J; 2016 Mar; 13():45. PubMed ID: 26993620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza.
    Tabynov K; Kydyrbayev Zh; Ryskeldinova Sh; Assanzhanova N; Sansyzbay A
    Vaccine; 2014 May; 32(25):2965-71. PubMed ID: 24726250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
    Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred.
    van Maanen C; van Essen GJ; Minke J; Daly JM; Yates PJ
    Vet Microbiol; 2003 Jun; 93(4):291-306. PubMed ID: 12713892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses induced by Japanese whole inactivated vaccines against equine influenza virus (H3N8) belonging to Florida sublineage clade2.
    Yamanaka T; Bannai H; Nemoto M; Tsujimura K; Kondo T; Matsumura T
    J Vet Med Sci; 2011 Apr; 73(4):483-5. PubMed ID: 21099188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
    Soboll G; Hussey SB; Minke JM; Landolt GA; Hunter JS; Jagannatha S; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):100-107. PubMed ID: 20018384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.